PlexinD1 is a driver and a therapeutic target in advanced prostate cancer
Abstract Aggressive prostate cancer (PCa) variants associated with androgen receptor signaling inhibitor (ARSI) resistance and metastasis remain poorly understood. Here, we identify the axon guidance semaphorin receptor PlexinD1 as a crucial driver of cancer aggressiveness in metastatic castration-r...
-д хадгалсан:
| Үндсэн зохиолчид: | , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
Springer Nature
2025-01-01
|
| Цуврал: | EMBO Molecular Medicine |
| Нөхцлүүд: | |
| Онлайн хандалт: | https://doi.org/10.1038/s44321-024-00186-z |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|
